Skip to content

Designing and Implementing Intervention Program to Relapse Prevention among Addicts

Designing and Implementing Intervention Program to Relapse Prevention among Addicts Referred to Addiction Centers in Hamadan

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2013092314736N1
Enrollment
70
Registered
2013-10-05
Start date
2011-09-23
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prevention among Addicts Referred to Addiction Centers.

Interventions

Intervention 1: Training program for participants in the intervention group training ten sessions were held for 45 to 60 minutes. Session 1: Physiology of Addiction Session 2: Complications and conseq
Prevention
Training program for participants in the intervention group training ten sessions were held for 45 to 60 minutes. Session 1: Physiology of Addiction Session 2: Complications and consequences of drug
In the control group: No Action

Sponsors

Research Center for Behavioral Disorders and Substance Abuse, Hamadan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: Inclusion criteria: volunteers reffered to leave the drugs, and willingness to cooperate. Exclusion criteria: absent in two education sessions or treatment.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Relapse. Timepoint: Starting the intervention and three months post-intervention. Method of measurement: Morphine test.

Secondary

MeasureTime frame
Behavioral intention. Timepoint: Before and three months after intervention. Method of measurement: Questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFarzad Jalilian

Hamadan University of Medical Sciences

f_jalilian@yahoo.com+98 31 7726 3623

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026